|Articles|February 29, 2012

Pfizer Acquires Emergen-C Maker

While the deal’s financial terms were not disclosed, the companies said that it will help expand Emergen-C distribution.

Drug firm Pfizer has acquired Alacer Corp., the maker of the Emergen-C line of effervescent vitamin C supplements. According to the companies, Emergen-C is the largest-selling vitamin C brand in the United States. Alacer, which had been privately held, produces nearly 500 million packets of product annually.

While the deal’s financial terms were not disclosed, the companies said that it will help expand Emergen-C distribution. “Emergen-C products add to and greatly complement our market-leading dietary supplement portfolio,” added Paul Sturman, president of Pfizer Consumer Healthcare, in a press release.


Related to this article

SupplySide Global Vitaquest
Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Michael Anthonavage, VP of innovation at Vitaquest International, about the company’s 2027 consumer trends forecast and how it’s shaping supplement formulation.
Laurentia Bliss
Live from SupplySide Global 2026, Laurentia Bliss talks about new athlete-focused research on Magtein, ThreoTech’s brain-targeted magnesium ingredient, and upcoming innovations like effervescent tablets and gummies.
Klaus Neumann
Live from SupplySide Global 2026, Klaus Neumann talks about Concordix's chewable supplement line spanning beauty and gut-immune health, including BeautyBioti, a Skin & Hair Vitality Complex, and FortiBiotic.